Picture Demy-Colton BioFuture 2024 NYC Game Changers 650x100px
Document › Details

Cellbox Solutions GmbH. (7/5/23). "Press Release: Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program".

Organisations Organisation Cellbox Solutions GmbH
  Group Cellbox Solutions (Group)
  Organisation 2 Akampion, Office Hamburg
  Today Akampion
  Group Akampion
Products Product Cellbox transportable CO2 incubator
  Product 2 business development (state/region)
Index term Index term Cellbox Solutions–EU (govt): grant, 202308–202507 EIC Accelerator grant €2.5m
Persons Person Adlkofer, Kathrin (ai:do concepts GmbH 20111– Managing Director before Norgenta 2005–201202 Managing Director)
  Person 2 Weß, Ludger (akampion before 2001–2006 BioCentury Senior Editor before Financial Times Deutschland)

Cellbox Solutions selected by the EIC following the second 2023 EIC Accelerator cut-off

Cellbox Solutions GmbH, a leading provider of warm chain logistics solutions for the research, development and shipment of cell-based therapies and cellular diagnostics, today announced that the Company has been awarded an initial grant of €2.5 million combined with an additional equity funding of up to €10 million under the European Innovation Council (EIC) Accelerator program sponsored by the European Union.

Cellbox has established a significant global footprint in the life sciences R&D sector by enabling academic and industrial groups to transport difficult-to-freeze and non-freezable cell types such as organoids, tissue patches, cellular 3D prints and others. The initial grant will be used to further develop the Cellbox technology for the workflow of clinical trials and cell therapies for the cell and gene technology market. The equity component will be used to expand Cellbox´ logistics services and establish logistics hubs in Europe, the U.S., and APAC.

The two-year €2.5 million grant will be disbursed in August 2023 and will be complemented by the EIC Fund’s equity investment starting in early 2024.

“We are very proud that the EIC Accelerator jury has chosen to support Cellbox in the development and commercialization of its sophisticated warm chain logistics solutions in a fierce competition among numerous European start-up applicants,” said Kathrin Adlkofer, Prof. PhD, Founder of Cellbox Solutions GmbH. “Our goal is to bring our innovative and enabling live cell transport technology to key healthcare markets and ultimately to patients in Europe, the U.S. and Asia-Pacific.”

Cellbox Solutions´ technology is based on a unique portable live cell transport incubator combined with leading-edge live cell logistics solutions for healthcare companies.


About Cellbox Solutions GmbH

Founded in 2017, Cellbox Solutions GmbH focuses on innovative logistics solutions for the global healthcare industry, enabling transport logistics for difficult-to-freeze cells and clinical developers to deliver cell therapies to patients under the best physiological conditions. The Company´s portable CO2 incubator, Cellbox, provides a controlled and optimal environment for the transport of living cells and biological structures. Temperature and CO2 levels can be adjusted to ensure optimal incubation conditions. For more information, please visit

About the EIC and the EIC Accelerator Grant

The EIC was established by the European Commission as part of the EU´s Horizon Europe program. It provides funding to individual companies (mainly start-ups and SMEs) through both grants and investments. Investments currently take the form of direct equity or quasi-equity investments and are managed by the EIC Fund.

The EIC Accelerator offers start-ups and SMEs grants of up to €2.5 million ($2.5 million) combined with equity investments through the EIC Fund ranging from €500,000 to €15 million ($489,000 to $14.7 million) or more. In addition to financial support, all projects benefit from a range of business acceleration services that provide access to leading expertise, companies, investors and ecosystem players.

Contact Cellbox Solutions GmbH

Prof. Dr. Kathrin Adlkofer
COO and Founder
+49 40 226 316 450

Media Inquiries

Dr. Ludger Wess / Ines-Regina Buth
Managing Partners
Tel. +49 40 88 16 59 64 /Tel. +49 30 23 63 27 68

Record changed: 2024-01-20


Picture Demy-Colton BioFuture 2024 NYC 3 Healthcare Revolution 650x200px

More documents for Cellbox Solutions (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2024 NYC Reimagine Healthcare 650x300px

» top